Well i'm hesitant to answer because when ever i mention money people have babies about it lol
But really it comes down to cash - both 1102 for MS & 1103 for acromegaly where partnered - you either need money or deal it out and find a partner to carry you through.
Both drugs where handed back by their respective partners and the company didn't have the cash to continue carrying them along independently and have been unable to find new partners for them since.
Ann: ANP Submits US Orphan Drug application for ATL1102 in DMD, page-57
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.5¢ | $242.1K | 2.246M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47453 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 278209 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |